drugset / Trial / NCT02027753
Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
NaSingle-groupOpen-labelTreatment
Summary
Primary Objective: To investigate the efficacy(HbA1c) at 6 months after adding basal insulin therapy (insulin glargine) to dipeptidyl peptidase-IV (DPP-IV) and metformin plus or minus sulphonylurea Secondary Objectives: 1. To assess the efficacy by adding insulin glargine 2. To assess insulin dose 3. Safety
Timeline
- Start
- 2013-12
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | 0.2 unknown | Subcutaneous |
| Subject | insulin glargine | Protein / enzyme biologic | 10 unknown | Subcutaneous |
| Background | Metformin | Small molecule | — | Oral |